BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 25406943)

  • 1. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
    Rajendiran S; Parwani AV; Hare RJ; Dasgupta S; Roby RK; Vishwanatha JK
    Mol Cancer; 2014 Nov; 13():250. PubMed ID: 25406943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-κB/MMP-9/VEGF pathways.
    Li D; Wei Y; Wang D; Gao H; Liu K
    Biochem Biophys Res Commun; 2016 Apr; 472(3):465-70. PubMed ID: 26827826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
    Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
    Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
    Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
    Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
    Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
    Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.
    Ibrahim FF; Jamal R; Syafruddin SE; Ab Mutalib NS; Saidin S; MdZin RR; Hossain Mollah MM; Mokhtar NM
    J Ovarian Res; 2015 Aug; 8():56. PubMed ID: 26260454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel-miR-4885 Promotes Migration and Invasion of Esophageal Cancer Cells Through Targeting CTNNA2.
    Song J; Zhang P; Liu M; Xie M; Gao Z; Wang X; Wang T; Yin J; Liu R
    DNA Cell Biol; 2019 Feb; 38(2):151-161. PubMed ID: 30526004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-124-5p Inhibits the Progression of Gastric Cancer by Targeting MIEN1.
    Liang F; Zhang H; Qiu Y; Xu Q; Jian K; Jiang L; Wang F; Lu X
    Technol Cancer Res Treat; 2020; 19():1533033820979199. PubMed ID: 33349155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-194 suppresses prostate cancer migration and invasion by downregulating human nuclear distribution protein.
    Kong Q; Chen XS; Tian T; Xia XY; Xu P
    Oncol Rep; 2017 Feb; 37(2):803-812. PubMed ID: 27959429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
    Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIEN1 promotes oral cancer progression and implicates poor overall survival.
    Rajendiran S; Kpetemey M; Maji S; Gibbs LD; Dasgupta S; Mantsch R; Hare RJ; Vishwanatha JK
    Cancer Biol Ther; 2015; 16(6):876-85. PubMed ID: 25996585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.
    Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L
    J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2.
    Zhiping C; Shijun T; Linhui W; Yapei W; Lianxi Q; Qiang D
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4835-4843. PubMed ID: 29164579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.
    Liang J; Li Y; Daniels G; Sfanos K; De Marzo A; Wei J; Li X; Chen W; Wang J; Zhong X; Melamed J; Zhao J; Lee P
    Mol Cancer Res; 2015 Apr; 13(4):681-8. PubMed ID: 25587085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propofol Ameliorates the Proliferation and Epithelial-Mesenchymal Transition of Hepatoma Carcinoma Cells via Non-Coding RNA Activated by DNA Damage (NORAD)/microRNA (miR)-556-3p/Migration and Invasion Enhancer 1 (MIEN1) Axis.
    Liu Y; Wang X; Li H; Guan E; Luo K
    J Environ Pathol Toxicol Oncol; 2021; 40(4):87-97. PubMed ID: 34936303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.
    Kroiss A; Vincent S; Decaussin-Petrucci M; Meugnier E; Viallet J; Ruffion A; Chalmel F; Samarut J; Allioli N
    Oncogene; 2015 May; 34(22):2846-55. PubMed ID: 25065599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The circular RNA circ_0030018/miR-136/migration and invasion enhancer 1 (MIEN1) axis promotes the progression of polycystic ovary syndrome.
    Xu J; Qu Q; Liu B; Shen L
    Bioengineered; 2022 Mar; 13(3):5999-6011. PubMed ID: 35184658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.